These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 5681549)

  • 21. Effect of clofibrate on low-density lipoprotein turnover in essential hypercholesterolaemia.
    Scott PJ; Hurley PJ
    J Atheroscler Res; 1969; 9(1):25-34. PubMed ID: 5779579
    [No Abstract]   [Full Text] [Related]  

  • 22. [Action of a 2.2 percent solution of androsterone, in chlorphenisate, on the serum lipoproteins of low density (LDL) in patients resistant to diet therapy].
    Bertolami V; Schneiderman B; Finatti AA; Netto RF
    Arq Bras Cardiol; 1966 Apr; 19(2):111-26. PubMed ID: 5943772
    [No Abstract]   [Full Text] [Related]  

  • 23. [CPIB: a hypolipidemic agent. Study of 20 patients].
    Verdy M
    Union Med Can; 1966 Sep; 95(9):1049-52. PubMed ID: 5913817
    [No Abstract]   [Full Text] [Related]  

  • 24. A three-year trial of atromid therapy in exudative diabetic retinopathy.
    Duncan LJ; Cullen JF; Ireland JT; Nolan J; Clarke BF; Oliver MF
    Diabetes; 1968 Jul; 17(7):458-67. PubMed ID: 4875170
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV
    Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
    [No Abstract]   [Full Text] [Related]  

  • 26. [Long-term treatment of previously therapy-resistant cases of primary hypertriglyceridemia of the adult with ethyl-p-chlorophenoxyisobutyrate].
    Braunsteiner H; Herbst M; Sandhofer F; Sailer S
    Dtsch Med Wochenschr; 1967 Dec; 92(50):2302-8. PubMed ID: 6075896
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical experimentation with CPIB (with or without androsterone) in the treatment of hyperlipemia. Apropos of 35 cases].
    Warembourg H; Jaillard J
    Lille Med; 1965 Apr; 10(4):431-6. PubMed ID: 5318637
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate].
    Barisone D; Gallo G; Accardo S
    Minerva Med; 1969 Jan; 60(6):174-80. PubMed ID: 5776766
    [No Abstract]   [Full Text] [Related]  

  • 29. [Drug therapy in hypercholesteremia].
    Heyden-Stucky S
    Schweiz Med Wochenschr; 1967 Apr; 97(14):451-63. PubMed ID: 5587006
    [No Abstract]   [Full Text] [Related]  

  • 30. THE EFFECTS OF CHLOROPHENOXYISOBUTYRATE WITH AND WITHOUT ANDROSTERONE ON THE SERUM LIPIDS, FAT TOLERANCE, AND URIC ACID.
    BERKOWITZ D
    Metabolism; 1965 Sep; 14():966-75. PubMed ID: 14327273
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons].
    Rilliet B; Monnier J
    Praxis; 1969 Jun; 58(25):815-20. PubMed ID: 5819485
    [No Abstract]   [Full Text] [Related]  

  • 32. Laboratory indices in clofibrate therapy of juvenile-onset diabetes.
    Narduzzi JV; Danowski TS; Weir TF; Alley RA; Vester JW; Moses C
    Clin Pharmacol Ther; 1967; 8(6):817-23. PubMed ID: 4862480
    [No Abstract]   [Full Text] [Related]  

  • 33. [Association of neomycin sulfate and ethyl-p-chlorophenoxybutyrate in the treatment of dyslipemia].
    Bertulla A; Bertamino V; Solari E
    Ateneo Parmense 1; 1971; 42(2):103-14. PubMed ID: 5154400
    [No Abstract]   [Full Text] [Related]  

  • 34. New drugs for the treatment of hypercholesterolemia.
    Hamlin JT
    Va Med Mon (1918); 1969 Jan; 96(1):11-2. PubMed ID: 5763103
    [No Abstract]   [Full Text] [Related]  

  • 35. Atromid and platelet adhesiveness in multiple sclerosis.
    Millac P; Caspary EA; Prineas J
    J Atheroscler Res; 1967; 7(3):397-400. PubMed ID: 5340971
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypolipidemic effect of chlorophenoxyisobutyrate in adult-onset diabetes mellitus.
    Danowski TS; Novak JF; Saul RW; Vester JW; Moses C
    Clin Pharmacol Ther; 1966; 7(5):631-8. PubMed ID: 5957168
    [No Abstract]   [Full Text] [Related]  

  • 37. TRIAL OF A CHOLESTEROL-REDUCING AGENT. A PRELIMINARY COMMUNICATION.
    CHHETRI MK; CHOWDHURY ND
    J Indian Med Assoc; 1965 May; 44():524-9. PubMed ID: 14313804
    [No Abstract]   [Full Text] [Related]  

  • 38. Clofibrate in glaucoma.
    Orbán T
    Lancet; 1968 Jan; 1(7532):47. PubMed ID: 4169091
    [No Abstract]   [Full Text] [Related]  

  • 39. REDUCTION OF SERUM TRIGLYCERIDES AND CHOLESTEROL BY ETHYL P-CHLOROPHENOXY-ISOBUTYRATE (CPIB).
    BEST MM; DUNCAN CH
    Am J Cardiol; 1965 Feb; 15():230-3. PubMed ID: 14254816
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of clofibrate on open-angle glaucoma.
    Marrs JM; Rowe KW
    Arch Ophthalmol; 1969 Jul; 82(1):19-20. PubMed ID: 5791497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.